Shares of biotech firm Recursion Pharmaceuticals, in which Nvidia invested nearly $76 million, gained 5%. Last year, Nvidia had said it would invest in it to speed up training of the Utah-based firm's AI models for drug discovery. Read The Rest at :
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.
